welcomebonus100slot| Shanghai Pharmaceutical: Holding subsidiary Sakubatral-Valsartan Sodium Tablets approved for production

Securities Times e Company Newswelcomebonus100slot, Shanghai Pharmaceutical (601607)(601607) announced on the evening of May 14 that recently, the company's controlling subsidiary Changzhou Pharmaceutical Factory Co., Ltd.welcomebonus100slotSacubatrivalsartan sodium tablets received the "Drug Registration Certificate" issued by the State Food and Drug Administration, and the drug was approved for production. Sacubatryl Valsartan Sodium Tablets are mainly used to treat symptoms such as chronic heart failure and essential hypertension.